about
Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy.Glioblastoma of pineal region: report of four cases and literature review.Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer.Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma.MGMT promoter methylation in Peruvian patients with glioblastoma.Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy.Critical review of axillary recurrence in early breast cancerDistribution of tumor-infiltrating immune cells in glioblastomaPrognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapyImpact of pathological features of brain metastases in prognosis[Tuberculosis That Mimics Cancer: Cases Referred to the National Institute of Neoplastic Diseases, Lima-Peru]Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignanciesHelicobacter Pylori Detected in Tap Water of Peruvian Patients with Gastric CancerRelationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanomaRole of undifferentiation markers and androgen receptor expression in triple-negative breast cancerLatin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology ApproachPrevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric CancerPitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
P50
Q37323748-D65EBFC3-8EF5-4CCC-A1D1-5BE7F0E7FEF6Q48027884-741F8BBD-3C16-4AC5-86B0-F12A18FBB9E6Q48213913-5F462985-45C7-4E24-A554-EE1A82A6E8DDQ48333472-DD65554C-895B-4D4E-8A17-1F7A442ADAB0Q48850918-158E5D7C-69CE-4026-B4F2-75A685BE7265Q55070764-77A0B08A-2C71-44CE-9E69-F46D8E1D38EAQ55140281-6125C351-FEF5-456B-AD67-1E9751F2F420Q55275119-31302827-91E6-45FB-BB86-D00DC784C197Q57106758-D402D99B-F0BA-4F21-89E7-788197776067Q57288270-A11A290F-70F9-4427-B26D-BA2D70044D40Q60681783-1BF50233-26F2-4939-99FA-720F09294DAEQ88480224-97532EA8-BA6B-4CB6-AE0D-407D37BE1349Q89165669-1A9368C1-F13F-41BE-91A5-A9ABED9A127AQ90765065-BBEA0F30-E6BD-4914-92A3-3895F69272F3Q91411543-9F890974-3561-40DB-B8D8-F38ACA446487Q91696224-BC9A8582-2A18-4074-8563-1E8E9BE86FC9Q92099466-2424D822-F58C-4A1A-A213-5AFD1323F4C5Q92542037-F33FC6F7-C2EC-46D1-AFDC-E47096DAEDBBQ93073297-4B715F09-D25E-4759-8117-373B6C92E187Q94927810-CCD3A516-1DFD-437F-95BF-5C3F5DBEEAC4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Miluska Castillo
@ast
Miluska Castillo
@en
Miluska Castillo
@es
Miluska Castillo
@nl
type
label
Miluska Castillo
@ast
Miluska Castillo
@en
Miluska Castillo
@es
Miluska Castillo
@nl
prefLabel
Miluska Castillo
@ast
Miluska Castillo
@en
Miluska Castillo
@es
Miluska Castillo
@nl
P106
P1153
56401535100
P31
P496
0000-0002-0111-3176